chronic myeloid leukemia
FDA Grants Accelerated Approval to Scemblix for Newly Diagnosed Chronic Myeloid Leukemia
The FDA granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed ...
OCTOBER 30, 2024
Stopping TKIs Can Be Done Safely While Slashing Cost of Therapy
Discontinuing tyrosine kinase inhibitors is safe for patients with chronic myeloid leukemia who have mounted a deep ...
MAY 5, 2023
Strategies for Stopping TKIs in CML Growing Clearer
San Diego—In patients with CML, longer treatment duration is associated with an increase in the odds ratio ...
MARCH 14, 2017
Load more